The quality of anticoagulation on functional outcome and mortality for TIA/stroke in atrial fibrillation patients

Daniela Poli, Emilia Antonucci, Rossella Marcucci, Lucia Mannini, Michela Falciani, Rosanna Abbate, Gian Franco Gensini, Domenico Prisco

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Background: In atrial fibrillation (AF) patients stroke is nearly twice as likely to be fatal as non-AF patients and functional deficits are more likely to be severe among survivors. The incidence of stroke among AF patients is greatly reduced by oral anticoagulant treatment (OAT). However, fluctuation of anticoagulation levels is intrinsically related to OAT and often international normalized ratio (INR) is out of the therapeutic range. Methods: Since the "anticoagulation history" is an ongoing process, we performed this prospective study in 578 AF patients to investigate the role of the whole quality of OAT and of INR levels at the occurrence of transient ischemic attack (TIA) or stroke on the severity of cerebral ischemia. Results: During follow-up 13 patients had TIA and 18 had stroke (rate 1.67 × 100 pt/years). In relation to the quality of anticoagulant treatment, no significant differences were found in the time spent below and within the intended therapeutic range, between patients with and without TIA/stroke. Patients with TIA/stroke spent a longer time above the intended therapeutic range with respect to other patients, even if this difference was not confirmed at multivariate analysis. Forty-six percent of patients with TIA and 66% of patients with stroke had INR ≥ 2 at the occurrence of ischemic event. Conclusion: The severity of stroke was not related to the whole quality of anticoagulation or to INR at the event.

Original languageEnglish
Pages (from-to)109-113
Number of pages5
JournalInternational Journal of Cardiology
Volume132
Issue number1
DOIs
Publication statusPublished - Feb 6 2009

Fingerprint

Transient Ischemic Attack
Atrial Fibrillation
Stroke
Mortality
International Normalized Ratio
Anticoagulants
Therapeutics
Brain Ischemia
Survivors
Multivariate Analysis
History
Prospective Studies

Keywords

  • Atrial fibrillation
  • Mortality
  • Oral anticoagulant
  • Severity
  • Stroke
  • TIA

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

The quality of anticoagulation on functional outcome and mortality for TIA/stroke in atrial fibrillation patients. / Poli, Daniela; Antonucci, Emilia; Marcucci, Rossella; Mannini, Lucia; Falciani, Michela; Abbate, Rosanna; Gensini, Gian Franco; Prisco, Domenico.

In: International Journal of Cardiology, Vol. 132, No. 1, 06.02.2009, p. 109-113.

Research output: Contribution to journalArticle

Poli, D, Antonucci, E, Marcucci, R, Mannini, L, Falciani, M, Abbate, R, Gensini, GF & Prisco, D 2009, 'The quality of anticoagulation on functional outcome and mortality for TIA/stroke in atrial fibrillation patients', International Journal of Cardiology, vol. 132, no. 1, pp. 109-113. https://doi.org/10.1016/j.ijcard.2007.10.041
Poli, Daniela ; Antonucci, Emilia ; Marcucci, Rossella ; Mannini, Lucia ; Falciani, Michela ; Abbate, Rosanna ; Gensini, Gian Franco ; Prisco, Domenico. / The quality of anticoagulation on functional outcome and mortality for TIA/stroke in atrial fibrillation patients. In: International Journal of Cardiology. 2009 ; Vol. 132, No. 1. pp. 109-113.
@article{8ab57db98f8a43608cd6ca78073f9026,
title = "The quality of anticoagulation on functional outcome and mortality for TIA/stroke in atrial fibrillation patients",
abstract = "Background: In atrial fibrillation (AF) patients stroke is nearly twice as likely to be fatal as non-AF patients and functional deficits are more likely to be severe among survivors. The incidence of stroke among AF patients is greatly reduced by oral anticoagulant treatment (OAT). However, fluctuation of anticoagulation levels is intrinsically related to OAT and often international normalized ratio (INR) is out of the therapeutic range. Methods: Since the {"}anticoagulation history{"} is an ongoing process, we performed this prospective study in 578 AF patients to investigate the role of the whole quality of OAT and of INR levels at the occurrence of transient ischemic attack (TIA) or stroke on the severity of cerebral ischemia. Results: During follow-up 13 patients had TIA and 18 had stroke (rate 1.67 × 100 pt/years). In relation to the quality of anticoagulant treatment, no significant differences were found in the time spent below and within the intended therapeutic range, between patients with and without TIA/stroke. Patients with TIA/stroke spent a longer time above the intended therapeutic range with respect to other patients, even if this difference was not confirmed at multivariate analysis. Forty-six percent of patients with TIA and 66{\%} of patients with stroke had INR ≥ 2 at the occurrence of ischemic event. Conclusion: The severity of stroke was not related to the whole quality of anticoagulation or to INR at the event.",
keywords = "Atrial fibrillation, Mortality, Oral anticoagulant, Severity, Stroke, TIA",
author = "Daniela Poli and Emilia Antonucci and Rossella Marcucci and Lucia Mannini and Michela Falciani and Rosanna Abbate and Gensini, {Gian Franco} and Domenico Prisco",
year = "2009",
month = "2",
day = "6",
doi = "10.1016/j.ijcard.2007.10.041",
language = "English",
volume = "132",
pages = "109--113",
journal = "International Journal of Cardiology",
issn = "0167-5273",
publisher = "Elsevier Ireland Ltd",
number = "1",

}

TY - JOUR

T1 - The quality of anticoagulation on functional outcome and mortality for TIA/stroke in atrial fibrillation patients

AU - Poli, Daniela

AU - Antonucci, Emilia

AU - Marcucci, Rossella

AU - Mannini, Lucia

AU - Falciani, Michela

AU - Abbate, Rosanna

AU - Gensini, Gian Franco

AU - Prisco, Domenico

PY - 2009/2/6

Y1 - 2009/2/6

N2 - Background: In atrial fibrillation (AF) patients stroke is nearly twice as likely to be fatal as non-AF patients and functional deficits are more likely to be severe among survivors. The incidence of stroke among AF patients is greatly reduced by oral anticoagulant treatment (OAT). However, fluctuation of anticoagulation levels is intrinsically related to OAT and often international normalized ratio (INR) is out of the therapeutic range. Methods: Since the "anticoagulation history" is an ongoing process, we performed this prospective study in 578 AF patients to investigate the role of the whole quality of OAT and of INR levels at the occurrence of transient ischemic attack (TIA) or stroke on the severity of cerebral ischemia. Results: During follow-up 13 patients had TIA and 18 had stroke (rate 1.67 × 100 pt/years). In relation to the quality of anticoagulant treatment, no significant differences were found in the time spent below and within the intended therapeutic range, between patients with and without TIA/stroke. Patients with TIA/stroke spent a longer time above the intended therapeutic range with respect to other patients, even if this difference was not confirmed at multivariate analysis. Forty-six percent of patients with TIA and 66% of patients with stroke had INR ≥ 2 at the occurrence of ischemic event. Conclusion: The severity of stroke was not related to the whole quality of anticoagulation or to INR at the event.

AB - Background: In atrial fibrillation (AF) patients stroke is nearly twice as likely to be fatal as non-AF patients and functional deficits are more likely to be severe among survivors. The incidence of stroke among AF patients is greatly reduced by oral anticoagulant treatment (OAT). However, fluctuation of anticoagulation levels is intrinsically related to OAT and often international normalized ratio (INR) is out of the therapeutic range. Methods: Since the "anticoagulation history" is an ongoing process, we performed this prospective study in 578 AF patients to investigate the role of the whole quality of OAT and of INR levels at the occurrence of transient ischemic attack (TIA) or stroke on the severity of cerebral ischemia. Results: During follow-up 13 patients had TIA and 18 had stroke (rate 1.67 × 100 pt/years). In relation to the quality of anticoagulant treatment, no significant differences were found in the time spent below and within the intended therapeutic range, between patients with and without TIA/stroke. Patients with TIA/stroke spent a longer time above the intended therapeutic range with respect to other patients, even if this difference was not confirmed at multivariate analysis. Forty-six percent of patients with TIA and 66% of patients with stroke had INR ≥ 2 at the occurrence of ischemic event. Conclusion: The severity of stroke was not related to the whole quality of anticoagulation or to INR at the event.

KW - Atrial fibrillation

KW - Mortality

KW - Oral anticoagulant

KW - Severity

KW - Stroke

KW - TIA

UR - http://www.scopus.com/inward/record.url?scp=58849160482&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58849160482&partnerID=8YFLogxK

U2 - 10.1016/j.ijcard.2007.10.041

DO - 10.1016/j.ijcard.2007.10.041

M3 - Article

VL - 132

SP - 109

EP - 113

JO - International Journal of Cardiology

JF - International Journal of Cardiology

SN - 0167-5273

IS - 1

ER -